Bill Ackman Called Howard Hughes Holdings a "Compounding Machine" He Wants to Turn Into a Trillion-Dollar Business Over the Next 50 Years. Here's Why the Market Might Be Underpricing That Bet.

Bill Ackman's Pershing Square bought a controlling stake of Howard Hughes last year at a premium price. Investors are heavily discounting that price today.

The Motley Fool • Oct 7, 2026

Howard Hughes Holdings: Double Bottom, A New Insurance Engine, And A Second Chance For The Breakout

Howard Hughes Holdings is transitioning from a pure land developer to a diversified holding company with real estate and insurance engines. Vantage's acquisition defines 2026, adding an insurance engine, while Pershing Square's $1 billion preferred adds complexity to the valuation. Trading about 29% below Pershing's $100 entry and near $71, HHH sits well below my $95–$115 fair value, supported by strong core real estate results.

Seeking Alpha • Oct 5, 2026

Howard Hughes Unveils Insurance-Led Strategy After Board Wins Strong Support

Howard Hughes NYSE: HHH shareholders elected all 11 board nominees, approved the company's advisory executive-compensation proposal and ratified KPMG as independent auditor for 2026, according to preliminary results announced at the company's annual meeting.

MarketBeat • Oct 4, 2026

Howard Hughes: Still Attractive Despite Risks Of Rapid Transition

Howard Hughes is accelerating its transformation, monetizing real estate assets to rapidly grow its insurance arm, Vantage. HHH plans to sell up to 80% of operating real estate assets and 100% of condos, raising nearly $4 billion for redeployment into insurance. This shift increases risk, as asset sales may face pricing pressure and the insurance unit must deploy new capital prudently.

Seeking Alpha • Oct 3, 2026

Howard Hughes Holdings Inc. (HHH) Shareholder/Analyst Call Transcript

Howard Hughes Holdings Inc. (HHH) Shareholder/Analyst Call Transcript

Seeking Alpha • Oct 1, 2026

Ackman Talks Howard Hughes Plans, IPOs and Anthropic

Pershing Square founder and CEO Bill Ackman discusses his plans for Howard Hughes, the state of the IPO market and his views on AI and Anthropic. Speaking with Dani Burger on "Bloomberg Deals," Ackman also comments on his daughter's illness, which inspired him to invest in a new medical institute.

Bloomberg Markets and Finance • Sep 30, 2026

Does Howard Hughes Holdings (HHH) Have the Potential to Rally 31.04% as Wall Street Analysts Expect?

The mean of analysts' price targets for Howard Hughes Holdings (HHH) points to a 31% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Zacks Investment Research • Sep 28, 2026

Reminder: HHH 2026 Annual Shareholder Meeting Set for September 30

GlobeNewsWire • Sep 25, 2026

Howard Hughes Stock Rises After Executives Buy Shares Following Ackman Post

Howard Hughes executives Marc Grandisson and Andrew Davis bought shares Wednesday, according to SEC filings.

Barrons • Sep 25, 2026

Howard Hughes Holdings (HHH) Moves 8.9% Higher: Will This Strength Last?

Howard Hughes Holdings (HHH) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Zacks Investment Research • Sep 22, 2026